<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03107858</url>
  </required_header>
  <id_info>
    <org_study_id>NorepivsDopamine</org_study_id>
    <nct_id>NCT03107858</nct_id>
  </id_info>
  <brief_title>The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function</brief_title>
  <official_title>The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Renal transplantation is now recognized as a treatment of choice for patients with chronic
      renal failure with end-stage renal disease. Renal transplantations are associated with better
      quality of life, better cost/benefit ratio, and possibly longer survival. Significant changes
      in blood pressure are common throughout the surgical procedure for kidney transplantation.
      All efforts are made to maintain an appropriate level of blood pressure by using an adequate
      intravascular volume and vasopressor administration. All efforts are made to maintain an
      appropriate level of blood pressure by using an adequate intravascular volume and vasopressor
      administration. All efforts are made to maintain an appropriate level of blood pressure by
      using an adequate intravascular volume and vasopressor administration. All efforts are made
      to maintain an appropriate level of blood pressure by using an adequate intravascular volume
      and vasopressor administration.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum creatinine</measure>
    <time_frame>four hours postoperatively</time_frame>
    <description>postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood urea</measure>
    <time_frame>four hours postoperatively</time_frame>
    <description>postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine output</measure>
    <time_frame>over 24 hours</time_frame>
    <description>postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal artery diameter</measure>
    <time_frame>four hours postoperatively</time_frame>
    <description>Measured postoperative through renal artery Doppler</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal artery blood flow</measure>
    <time_frame>four hours postoperatively</time_frame>
    <description>Measured postoperative through renal artery Doppler</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Renal Transplant</condition>
  <arm_group>
    <arm_group_label>Norepinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dopamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Norepinephrine infusion will be used at a starting dose of 0.05μg/kg/min. Dose range: 0.05 -0.15 μg/kg/min. Infusion will be started with arterial decamping and continues till 24 hours postoperative</description>
    <arm_group_label>Norepinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dopamine</intervention_name>
    <description>Dopamine infusion will be used at a starting dose of 5μg/kg/min. Dose range: 5 -15 μg/kg/min. Infusion will be started with arterial decamping and continues till 24 hours postoperative</description>
    <arm_group_label>Dopamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for a living donor kidney transplantation

        Exclusion Criteria:

          -  Patients (less than 18 years old)

          -  Patients' refusal of consenting for enrolment in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Elkadi, MBBC</last_name>
    <phone>+201007485190</phone>
    <email>ahmedkader333@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Elkadi</last_name>
      <phone>01007485190</phone>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Abdel Kader Ahmed Mohammed Elkadi</investigator_full_name>
    <investigator_title>Specialist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Dopamine Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

